Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood BM, Diallo DA. Konaté AT, et al. Among authors: ouedraogo e, ouedraogo az, ouedraogo a, ouedraogo in. PLoS One. 2011;6(8):e23391. doi: 10.1371/journal.pone.0023391. Epub 2011 Aug 12. PLoS One. 2011. PMID: 21858097 Free PMC article. Clinical Trial.
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Chilengi R, Soulama I, Luty AJ, Druilhe P, Cousens S, Nébié I. Sirima SB, et al. Among authors: ouedraogo e, ouedraogo al, ouedraogo a. PLoS One. 2009 Oct 26;4(10):e7549. doi: 10.1371/journal.pone.0007549. PLoS One. 2009. PMID: 19855847 Free PMC article. Clinical Trial.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood B, Diallo DA. Konaté AT, et al. Among authors: ouedraogo e, ouedraogo az, ouedraogo a, ouedraogo in. PLoS Med. 2011 Feb 1;8(2):e1000408. doi: 10.1371/journal.pmed.1000408. PLoS Med. 2011. PMID: 21304925 Free PMC article. Clinical Trial.
Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.
Sanou GS, Tiendrebeogo RW, Ouédraogo AL, Diarra A, Ouédraogo A, Yaro JB, Ouédraogo E, Verra F, Behr C, Troye-Blomberg M, Modiano D, Dolo A, Torcia MG, Traoré Y, Sirima SB, Nébié I. Sanou GS, et al. Among authors: ouedraogo e, ouedraogo al, ouedraogo a. BMC Res Notes. 2012 Jan 27;5:76. doi: 10.1186/1756-0500-5-76. BMC Res Notes. 2012. PMID: 22283984 Free PMC article.
Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso.
Bougouma EC, Tiono AB, Ouédraogo A, Soulama I, Diarra A, Yaro JB, Ouédraogo E, Sanon S, Konaté AT, Nébié I, Watson NL, Sanza M, Dube TJ, Sirima SB. Bougouma EC, et al. Among authors: ouedraogo e, ouedraogo a. Malar J. 2012 May 4;11:154. doi: 10.1186/1475-2875-11-154. Malar J. 2012. PMID: 22559271 Free PMC article.
Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.
Ouédraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, Bougouma EC, Soulama I, Gansané A, Ouedraogo A, Konate AT, Nebie I, Watson NL, Sanza M, Dube TJ, Sirima SB. Ouédraogo A, et al. Among authors: ouedraogo e. PLoS One. 2013;8(1):e50036. doi: 10.1371/journal.pone.0050036. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320064 Free PMC article.
Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies.
Gansane A, Ouedraogo IN, Henry NB, Soulama I, Ouedraogo E, Yaro JB, Diarra A, Benjamin S, Konate AT, Tiono A, Sirima SB. Gansane A, et al. Among authors: ouedraogo e, ouedraogo in. Mem Inst Oswaldo Cruz. 2013 Aug;108(5):644-50. doi: 10.1590/0074-0276108052013017. Mem Inst Oswaldo Cruz. 2013. PMID: 23903982 Free PMC article.
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.
Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB. Ouédraogo A, et al. Among authors: ouedraogo e. PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013. PLoS One. 2013. PMID: 24244339 Free PMC article. Clinical Trial.
61 results